Related Experiment Video

Updated: Jul 11, 2026

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration
11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

Increased phosphorylation of Akt in triple-negative breast cancers

Shinobu Umemura1, Sei Yoshida, Yoshikazu Ohta

  • 1Department of Pathology, Tokai University School of Medicine, Isehara, Kanagawa 259-1193, Japan. umemura@is.icc.u-tokai.ac.jp

Cancer Science
|September 26, 2007
PubMed

Insights

Triple-negative breast cancers show high cell proliferation. This study found significantly increased Akt pathway activation in these cancers, offering new insights into their growth mechanisms.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Triple-negative breast cancers (TNBC) lack estrogen receptors (ER), progesterone receptors (PgR), and HER2, yet exhibit high cell proliferation.
  • The underlying mechanisms and signaling pathways driving TNBC proliferation remain poorly understood.

Purpose of the Study:

  • To investigate the signal transduction characteristics in triple-negative breast cancers.
  • To identify key molecular pathways involved in TNBC growth.

Main Methods:

  • Western blotting was used to analyze protein phosphorylation in 44 TNBC tumor samples.
  • Examined phosphorylation of HER2, ERK1/2, and Akt.
  • Immunohistochemical analysis assessed ER and HER2 phenotypes.

Main Results:

  • HER2 phosphorylation was observed in 26.7% of HER2-positive samples.
  • Elevated ERK1/2 phosphorylation was detected in triple-negative breast cancers.
  • Significantly higher Akt kinase phosphorylation was a key characteristic of TNBCs.

Conclusions:

  • Triple-negative breast cancers exhibit increased Akt kinase phosphorylation.
  • A subset of TNBCs demonstrates a significantly activated Akt pathway, representing a novel finding.

More Related Videos

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model09:29

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on: March 20, 2020

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...